Lívio Pereira de Macêdo | Vitamin D | Best Researcher Award

Posted on by Pencis
Mr. Lívio Pereira de Macêdo, Hospital da Restauração, Brazil

Mr. Lívio Pereira de Macêdo is a dedicated healthcare professional at Hospital da Restauração in Brazil. With a strong commitment to patient care, he has been actively involved in various medical initiatives aimed at improving healthcare delivery and patient outcomes. His expertise encompasses a range of medical practices, and he is known for his collaborative approach, working closely with multidisciplinary teams to enhance the quality of care. Mr. de Macêdo is passionate about advancing healthcare practices and is continually engaged in professional development to stay abreast of the latest medical advancements.

Profile:
Orcid Profile

Education:

Mr. Lívio Pereira de Macêdo is currently pursuing a Master’s degree in Applied Biology to Health at the Universidade Federal de Pernambuco (UFPE), Brazil, under the guidance of Advisor Hildo Rocha Cirne Azevedo-Filho. His research focuses on the impact of Vitamin D on health issues such as ruptured cerebral aneurysms and subarachnoid hemorrhages, within the broader field of Health Sciences and the specialization of Clinical Medicine and Neurology. In addition to his master’s studies, Mr. de Macêdo is undertaking a medical residency in Neurosurgery at Hospital da Restauração, Brazil. He earned his Bachelor’s degree in Medicine from Faculdade Integral Diferencial (FACID) from 2011 to 2016, where he was mentored by Kelson James Silva de Almeida. Mr. de Macêdo’s academic and clinical training positions him as a dedicated professional in the medical field, with a strong emphasis on advancing knowledge in neurology and health sciences.

Professional Development

Mr. Lívio Pereira de Macêdo has pursued a range of complementary educational experiences to enhance his medical expertise. In 2019, he participated in a Microsurgery Anatomy program at the Practical Anatomy and Surgical Education Lab at Saint Louis University (SLU), USA, earning 32 credit hours. His dedication to continuous learning is evident through his involvement in various continuing education programs, including a Cerebrovascular Diseases Study Group at the Federal University of Piauí (UFPI) in 2014, and an Introduction to Clinical Neurology course at the University of California, San Francisco (UCSF) in the same year. Additionally, he has engaged in courses focused on Neuroanatomy, Academic Neurology and Neurosurgery, and Basic Anatomy, further solidifying his foundation in health sciences. Mr. de Macêdo has also enhanced his language skills by completing a Basic English course at Curso de Inglês Prático (CIP) in 2005. These diverse educational experiences reflect his commitment to professional development in the medical field.

Professional Experience:

Mr. Lívio Pereira de Macêdo has gained valuable professional experience at various esteemed institutions in Brazil. Since 2022, he has been a government employee at Hospital da Restauração, contributing significantly to his role with 24 credit hours of service. He also began another government position at the same hospital in 2021, where he has continued to develop his skills and expertise. From 2014 to 2016, he was a scholarship recipient at Fundação Hospitalar de Teresina (FHT), where he dedicated himself exclusively to his role, accumulating 24 credit hours. Earlier, in 2013, he collaborated with FHT for 12 credit hours. In addition to his clinical experience, Mr. de Macêdo served as a Neuroanatomy Monitor at Faculdade Integral Diferencial (FACID) in 2012, accumulating 192 and 108 credit hours in two separate roles, as well as monitoring Anatomy II in 2011 for 161 credit hours. His diverse experiences reflect his commitment to advancing his knowledge and skills in the medical field.

Activities:

Mr. Lívio Pereira de Macêdo has been actively involved in several research projects at Campus I, contributing to important studies in the medical field. Since 2014, he has participated in a research project focused on the Evaluation of Visual Complaints in Patients with Idiopathic Parkinson’s Disease, which aims to enhance understanding of the visual challenges faced by these patients. In 2013, he contributed to a study examining the Rates of Severe Traumatic Brain Injury and Its Relation to Alcoholism in individuals admitted to an emergency hospital following automobile collisions, shedding light on critical public health issues. Additionally, in 2012, Mr. de Macêdo participated in a project investigating the Prevalence of Mycobacterium Tuberculosis Carriers among medical students at a higher education institution in Teresina-PI, addressing the importance of tuberculosis awareness and prevention in educational settings. His involvement in these projects demonstrates his dedication to advancing medical research and improving patient care.

Awards and Titles:

Mr. Lívio Pereira de Macêdo has received notable recognition for his contributions to the field of neurosurgery. In 2021, his work titled “Resection of a Left Insulo-Opercular Cavernoma in a 4-Year-Old Child: A Case Report” was awarded Second Place at the SBNPED Grand Round, held on October 23, 2021. This accolade highlights his dedication to advancing pediatric neurosurgical practices. In 2014, he secured Second Place in the Therapeutic Category at the XXVI Congress of the Ibero-Latin American Society of Diagnostic and Therapeutic Neuroradiology (SILAN), co-hosted by SILAN and SBNR, further underscoring his expertise in the field. Additionally, in 2013, he received an Honorable Mention for Second Place at the 10th Scientific Week of FACID, recognizing his commitment to scientific inquiry and innovation.

Conclusion:

Mr. Lívio Pereira de Macêdo is a dedicated medical professional specializing in neurosurgery, currently affiliated with Hospital da Restauração in Brazil. With a solid educational background, including a Master’s in Applied Biology to Health and ongoing medical residency, he has developed a strong foundation in health sciences and clinical neurology. His practical experience spans various roles in prominent medical institutions, where he has actively participated in research projects focused on neurological disorders and patient care. Lívio’s commitment to excellence has been recognized through multiple awards for his research contributions, reflecting his passion for advancing medical knowledge and improving patient outcomes. As he continues his journey in the medical field, his expertise and dedication are poised to make a significant impact in neurosurgery and beyond.

Top Notable Publications:

Vitamin D Deficiency and Intracranial Aneurysms: Systematic Review
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: World Neurosurgery: X
DOI: 10.1016/j.wnsx.2024.100413

Two Basilar Fenestration Aneurysms Management
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: ACTA Scientific Neurology
ISSN: 2582-1121

A utilização das tecnologias digitais na assistência em saúde
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: Revista Eletrônica Acervo Saúde
DOI: 10.25248/reas.e16136.2024
Part of ISSN: 2178-2091

Lesões de pele causadas pelo uso de EPIs durante a pandemia
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: Revista Eletrônica Acervo Saúde
DOI: 10.25248/reas.e16134.2024
Part of ISSN: 2178-2091

Middle meningeal artery embolization contraindication when it originates from the ophthalmic artery
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: Arquivos de Neuro-Psiquiatria
DOI: 10.1055/s-0044-1786023

The relationship between the level of vitamin D and ruptured intracranial aneurysms among patients with high sun exposure
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: Scientific Reports
DOI: 10.1038/s41598-024-53676-y
Part of ISSN: 2045-2322

Management of a ruptured posterior inferior cerebellar artery (PICA) aneurysm with end-to-end in situ bypass: Case report
Authors: Lívio Pereira de Macêdo
Year: 2023
Source: Journal of Cerebrovascular and Endovascular Neurosurgery
DOI: 10.7461/jcen.2023.e2023.05.006
Part of ISSN: 2287-3139

Vascular changes in patients diagnosed with sepsis: clinical epidemiology and public health aspects
Authors: Lívio Pereira de Macêdo
Year: 2023
Source: Editora IOLE
DOI: 10.5281/ZENODO.10313649

Traumatic spondylolisthesis of the axis without fracture: Case report and literature review
Authors: Lívio Pereira de Macêdo
Year: 2023
Source: Journal of Spine Research and Surgery
DOI: 10.26502/fjsrs0063
Part of ISSN: 2687-8046

Spontaneous anal extrusion of ventriculoperitoneal shunt catheter: Case report
Authors: Lívio Pereira de Macêdo
Year: 2022
Source: Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery
DOI: 10.1055/s-0042-1748848
Part of ISSN: 0103-5355, 2359-5922

 

 

Zhitao Li | Food Science | Best Researcher Award

Posted on by Pencis
Dr. Zhitao Li, Jiangnan University, China

Dr. Zhitao Li is a distinguished researcher at Jiangnan University, China. His expertise lies in food science and biotechnology, focusing on areas such as microbial fermentation, enzyme engineering, and food safety. Dr. Li has made significant contributions to the field through his research on fermentation technologies and their applications in food processing. He has authored numerous scientific publications and is recognized for advancing sustainable practices in food production. His work continues to impact both academia and the food industry, promoting innovation in food science.

Profile:
Orcid Profile

Academic Experience:

Dr. Zhitao Li is an Associate Researcher at Jiangnan University, China, where he has been serving since December 2023. Prior to this role, he held positions as a Postdoctoral Researcher and Assistant Researcher at the same university, contributing to advancements in fermentation engineering. Dr. Li earned his Ph.D. in Fermentation Engineering from Jiangnan University in 2021, following a Master’s degree in Animal Nutrition and Feed Science from Hebei University of Engineering in 2016. His research focuses on fermentation technologies, microbial engineering, and their applications in food and feed science.

Research Interests:

Dr. Zhitao Li, an Associate Researcher at Jiangnan University, China, focuses on cutting-edge research in the development and application of bionic digestive organ-on-chip systems. His work also emphasizes green biomanufacturing and the functional evaluation of nutraceuticals and specialized dietary products. Through his innovative research, Dr. Li aims to advance sustainable biomanufacturing technologies and improve the effectiveness of dietary supplements, contributing to both food science and human health.

Awards And Honors:

Dr. Zhitao Li, an Associate Researcher at Jiangnan University, China, has earned numerous accolades for his work in fermentation engineering and innovation. His recognitions include being named a National Excellent Postdoctoral Fellow (2021) and Jiangsu Provincial Excellence Postdoctoral Fellow (2022). He has also been honored with the National Outstanding Innovation and Entrepreneurship Mentor award (2022). Dr. Li has contributed to award-winning projects, including the First Prize in Science and Technology Progress by the China Light Industry Federation (2020) and the Jiangsu Provincial Science and Technology Second Prize (2021). His achievements also include top honors in national innovation and entrepreneurship competitions.

Research Projects:

Dr. Zhitao Li, an Associate Researcher at Jiangnan University, China, is the Principal Investigator of several prestigious research projects. He currently leads a project funded by the National Natural Science Foundation of China (Project No. 32372468, 2024-2027). Dr. Li has also completed two significant projects under the China Postdoctoral Science Foundation, including a Special Grant (2022T150272, 2022-2023) and a General Grant (2021M701463, 2021-2023), where he served as the Principal Investigator. His research continues to make impactful contributions in the fields of fermentation engineering and biomanufacturing.

Conclusion:

Dr. Zhitao Li is a distinguished researcher at Jiangnan University, China, whose work in fermentation engineering, biomanufacturing, and innovative technologies such as bionic digestive organ-on-chip systems has earned him numerous accolades and research grants. With a focus on sustainable practices and advancing the efficacy of nutraceuticals and specialized dietary products, Dr. Li’s contributions continue to push the boundaries of food science and biotechnology. His achievements reflect his leadership and innovation in his field, positioning him as a key figure in both academic and industrial advancements.

Top Notable Publications:

Li, Z.-T. (2023). In Vitro Digestion and Fecal Fermentation of Low-Gluten Rice and Its Effect on the Gut Microbiota. Foods, 12(4), 855. DOI: 10.3390/foods12040855.

Li, Z.-T. (2021). In vitro digestion and fecal fermentation of highly resistant starch rice and its effect on the gut microbiota. Food Chemistry, 358, 130095. DOI: 10.1016/j.foodchem.2021.130095.

 

 

Continue reading “Zhitao Li | Food Science | Best Researcher Award” →

Guido Sireci | Recent Advancements | Lifetime achievement Award

Posted on by Pencis
Assoc Prof Dr. Guido Sireci, BIND Università di Palermo, Italy

Assoc. Prof. Dr. Guido Sireci is an Associate Professor at the Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (BIND) at the Università di Palermo, Italy. His research focuses on immunology, particularly in understanding immune responses in infectious diseases and cancer. Dr. Sireci has contributed to numerous scientific publications and actively collaborates in both national and international research projects, advancing the field of biomedical sciences. He is recognized for his expertise in cellular immunology and the development of novel therapeutic approaches.

Profile:
Scopus Profile 

Education Qualification:

Assoc. Prof. Dr. Guido Sireci graduated from the Liceo Classico “G. Garibaldi” in Palermo in 1975 with a diploma in Classical Studies. He earned his degree in Biological Sciences from the University of Palermo in 1982, achieving a final grade of 105/110. In the same year, he obtained professional certification as a Biologist with the highest grade. Dr. Sireci began his specialization in General Pathology (now Clinical Pathology) at the University of Palermo in 1984 and completed it in 1987, graduating with a top grade of 50/50. His specialization thesis focused on the “Immunosuppressive Effects of Cyclosporine A.”

Teaching Activities:

Assoc. Prof. Dr. Guido Sireci has been engaged in academia at the University of Palermo since 1985, conducting theoretical and practical exercises in laboratory techniques, molecular biology, and immunology for students in the General Pathology and Genetics courses. From 1987 to 1989, he served as a lecturer in Immunology and General Pathology at the School of Professional Nursing, as well as lecturing in General Pathology at the Physiotherapy School and Chemistry at the Nursing School at Villa Sofia Hospital. He taught Immunopathology at the Faculty of Pharmacy from 1998 to 2000 and covered General Pathophysiology, General Pathology, and Immunology in the Nursing Diploma program in 1999. Since 2002, Dr. Sireci has been a lecturer in Immunology at the Faculty of Medicine and Surgery in Caltanissetta, and since 2010, he has taught General Pathology for the Nursing Science degree program at the Policlinico of Palermo.

Awards:

In 1999, Assoc. Prof. Dr. Guido Sireci was honored with the “Best Abstract Award” at the EFI Congress held in Montpellier, recognizing his significant contributions to the field of immunology. This accolade highlights his commitment to advancing research and knowledge within the scientific community.

Scientific Career:

Assoc. Prof. Dr. Guido Sireci has an extensive academic and research background. From 1985 to 1986, he specialized as a resident at the Institute of General Pathology (now the Department of Biopathology and Biomedical Methodologies) at the University of Palermo. In 1986, he was contracted as a Senior Technician at the Department of Immunobiology, Wellcome Research Laboratories, in London. He received a research grant from the Regional Health Department from 1987 to 1989 and was appointed as a Technical Officer at the Institute of General Pathology in 1990 after winning a public competition. Dr. Sireci was awarded a C.N.R. (National Research Council) scholarship in 1996 as a Visiting Scientist at the Transplantation Biology Group, Royal Postgraduate Medical School, Hammersmith Hospital, London. In 2001, he qualified for the position of Associate Professor at the Faculty of Medicine and Surgery at the University of Catania.

Conclusion:

Assoc. Prof. Dr. Guido Sireci is a distinguished academic and researcher in the field of General Pathology and Immunology. With a career spanning several decades, he has contributed significantly to both education and research, holding various positions at prestigious institutions such as the University of Palermo and Wellcome Research Laboratories in London. His expertise encompasses laboratory techniques, molecular biology, and immunological applications in experimental medicine. Dr. Sireci’s dedication to advancing knowledge in his field is evidenced by his numerous teaching roles, research grants, and recognition, including the “Best Abstract Award” at the EFI Congress. His ongoing commitment to education and research continues to impact future generations of medical professionals and scientists.

Top Notable Publications:

Maccora, S., Bolognini, N., Mannina, C., Sireci, G., Brighina, F.
The effects of estradiol levels on crossmodal perception: a study on the sound-induced flash illusion in healthy and menstrually related migraine individuals
Neurological Sciences, 2023, 44(8), pp. 2863–2870.
Citations: 0

Guggino, G., La Manna, M.P., Di Liberto, D., Sireci, G., Ciccia, F.
Interleukin 9 neutralisation reduces collagen-induced arthritis severity in mouse models
Clinical and Experimental Rheumatology, 2023, 41(1), pp. 94–102.
Citations: 5

Artigas-Jerónimo, S., González-García, A., de la Fuente, J., Torina, A., Sireci, G.
Low NETosis Induced in Anaplasma phagocytophilum-Infected Cells
Vaccines, 2022, 10(10), 1756.
Citations: 1

Mohammadnezhad, L., Shekarkar Azgomi, M., La Manna, M.P., Guggino, G., Caccamo, N., Sireci, G.
Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity
Cells, 2022, 11(10), 1663.
Citations: 10

Maggio, M.C., Failla, M.C., Giordano, S., Manna, M.P.L., Sireci, G.
Interleukin-6 Is a Promising Marker of COVID-19 in Children: A Case Series of 2 Brothers with Severe COVID-19 Pneumonia
American Journal of Case Reports, 2022, 23, e934468.
Citations: 3

Sireci, G., Badami, G.D., Di Liberto, D., de la Fuente, J., Torina, A.
Recent Advances on the Innate Immune Response to Coxiella burnetii
Frontiers in Cellular and Infection Microbiology, 2021, 11, 754455.
Citations: 16

de la Fuente, J., Armas, O., Sánchez-Rodríguez, L., Nova, R., Queirós, J., Sireci, G.
Citizen science initiative points at childhood BCG vaccination as a risk factor for COVID-19
Transboundary and Emerging Diseases, 2021, 68(6), pp. 3114–3119.
Citations: 9

Di Liberto, D., Scazzone, C., La Rocca, G., Guggino, G., Sireci, G.
Erratum: Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis
Clinical and Experimental Rheumatology, 2020, 38(6), pp. 1276.
Citations: 3

Torina, A., Blanda, V., Villari, S., de la Fuente, J., Sireci, G.
Immune response to tick-borne hemoparasites: Host adaptive immune response mechanisms as potential targets for therapies and vaccines
International Journal of Molecular Sciences, 2020, 21(22), pp. 1–22, 8813.
Citations: 13

Guggino, G., Schinocca, C., Lo Pizzo, M., Sarzi-Puttini, P., Dieli, F., Sireci, G.
Erratum: T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy
Clinical and Experimental Rheumatology, 2020, 38(6), pp. 1275.
Citations: 3

 

Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Posted on by Pencis

Dr.Stephane Manzo-Silberman | Cardiology | Best Researcher Award 

 Dr. Stephane Manzo-Silberman, APHP Sorbonne University, France

Dr. Stephane Manzo-Silberman is a renowned cardiologist at Assistance Publique-Hôpitaux de Paris (APHP) and a faculty member at Sorbonne University, France. She specializes in cardiovascular diseases, with a focus on coronary artery disease and interventions. Dr. Manzo-Silberman is actively involved in clinical research, particularly in the fields of interventional cardiology and thrombosis, and she has contributed extensively to academic publications in these areas. In addition to her clinical work, she plays a key role in advancing medical education and promoting innovative cardiovascular therapies.

Profile:

Scopus Profile 

 

Education Qualification:

Dr. Stéphane Manzo-Silberman, MD, MSc, completed her medical and clinical training in cardiology at René Descartes University, Paris, where she earned her Doctorate in Medical Sciences (2005) and specialized in cardiology. She also holds a Master’s degree in Biological Sciences (2004). Her clinical expertise was further developed during her residency in internal medicine and cardiology (2000-2005), followed by advanced training as a senior resident in interventional cardiology at Cochin Hospital (2006-2011) and in coronary angiography and angioplasty at Clinique Pasteur, Toulouse (2006), under the mentorship of Pr. J Marco and Dr. J Fajadet.

Current Position:

Dr. Stéphane Manzo-Silberman currently serves as Senior Consultant at the Cardiac Catheterization Laboratory and Coronary Care Unit of the Cardiology Institute at Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris. In this role, she specializes in interventional cardiology, managing complex cardiac procedures and providing advanced care for patients with coronary artery disease. Her position reflects her expertise in cardiovascular interventions and her dedication to improving clinical outcomes in cardiology.

Awards:

Dr. Stéphane Manzo-Silberman has received several prestigious awards throughout her career, including the French Society of Cardiology Prize for the best doctorate dissertation (2005) and the French Society of Angeology Junior Prize for the best master’s dissertation (2005). She was also honored with the Young Investigator Prize at JESFC 2017 and received an ESC Grant in 2020 to attend the Women Transforming Leadership Programme, highlighting her continued excellence in cardiology and leadership development.

Research Experience:

Dr. Stéphane Manzo-Silberman serves as the principal investigator in numerous multicenter academic clinical research studies. Her work includes leading pivotal studies such as the DOLORES registry, the DeFSSICA survey on acute heart failure management, and the First French Metaregistry on gender differences in myocardial infarction. She has also co-authored the EAPCI Women’s Survey on radiation protection in catheterization labs and chaired an EAPCI position statement on radiation protection during pregnancy for healthcare professionals. Additionally, she oversees major national projects like the WAMIF study on acute myocardial infarction in young women and the ACFA study on atrial fibrillation care pathways. Dr. Manzo-Silberman also actively directs theses and dissertations, mentoring the next generation of cardiology professionals.

Conclusion:

Dr. Stéphane Manzo-Silberman stands as a prominent figure in the field of cardiology, reflecting a deep commitment to advancing cardiovascular health and understanding. His extensive research, focused on the intricate dynamics of heart disease, particularly among diverse populations, underscores the critical importance of tailored medical approaches. Through his leadership in various studies and initiatives, Dr. Manzo-Silberman not only contributes to the scientific community but also advocates for improved patient outcomes and health equity. As he continues to explore new frontiers in cardiology, his work promises to inspire future generations of medical professionals and researchers, paving the way for innovative solutions to the challenges faced in cardiovascular care.

Top Notable Publications:

Laghlam, D., Benghanem, S., Ortuno, S., Hamzaoui, O., & Aissaoui, N. (2024). Management of cardiogenic shock: A narrative review. Annals of Intensive Care, 14(1), 45.

Sabouret, P., Barbato, E., Montalescot, G., Biondi-Zoccai, G., & Manzo-Silberman, S. (2024). Remembering our friend Jean-Philippe Collet: A giant in cardiology, a gentleman in life. Minerva Cardiology and Angiology, 72(4), 329-331.

Manzo-Silberman, S., Martin, A.-C., Boissier, F., Puymirat, E., & Delmas, C. (2024). Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. Journal of Critical Care, 82, 154785.

Manzo-Silberman, S., Guedeney, P., Cayla, G., Montalescot, G., & Silvain, J. (2024). Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients with Chronic Coronary Syndrome. JACC: Cardiovascular Interventions, 17(12), 1413-1421.

Manzo-Silberman, S., Montalescot, G., & Lebreton, G. (2024). Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials? Archives of Cardiovascular Diseases (Article in Press).

Hebbo, E., Khan, S., Manzo-Silberman, S., & Alasnag, M. (2024). The Clinical Approach to Angina in Women. Interventional Cardiology Clinics (Article in Press).

Manzo-Silberman, S., & Montalescot, G. (2023). Benefits of an observatory for myocardial infarction in women under 50: The WAMIF study. Annales de Cardiologie et d’Angeiologie, 72(6), 101691.

Manzo-Silberman, S., Chouihed, T., Ticelli, L.F., Roubille, F., & El Khoury, C. (2023). Assessment of atrial fibrillation in European emergency departments: Insights from a prospective observational multicenter study. Minerva Cardiology and Angiology, 74(4), 444-455.

Weizman, O., Tea, V., Marijon, E., Simon, T., & Danchin, N. (2023). Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Archives of Cardiovascular Diseases, 116(6-7), 324-334.

Sabouret, P., Manzo-Silberman, S., Alasnag, M., Biondi-Zoccai, G., & Bhatt, D.L. (2023). New approaches to reduce recurrent PCI: To angioplasty and beyond! European Heart Journal Open, 3(3), oead049.